SPY363.67+1.01 0.28%
DIA299.24+0.50 0.17%
IXIC12,205.85+111.44 0.92%

Morgan Stanley Initiates Coverage On Foghorn Therapeutics with Overweight Rating, Announces Price Target of $24

Morgan Stanley initiates coverage on Foghorn Therapeutics (NASDAQ:FHTX) with a Overweight rating and announces Price Target of $24.

· 11/17/2020 08:31
Morgan Stanley initiates coverage on Foghorn Therapeutics (NASDAQ:FHTX) with a Overweight rating and announces Price Target of $24.